333 related articles for article (PubMed ID: 16896036)
1. Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia.
Marshall JR; Sakr W; Wood D; Berry D; Tangen C; Parker F; Thompson I; Lippman SM; Lieberman R; Alberts D; Jarrard D; Coltman C; Greenwald P; Minasian L; Crawford ED
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1479-84. PubMed ID: 16896036
[TBL] [Abstract][Full Text] [Related]
2. Finasteride decreases the risk of prostatic intraepithelial neoplasia.
Thompson IM; Lucia MS; Redman MW; Darke A; La Rosa FG; Parnes HL; Lippman SM; Coltman CA
J Urol; 2007 Jul; 178(1):107-9; discussion 110. PubMed ID: 17499284
[TBL] [Abstract][Full Text] [Related]
3. Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial.
Price D; Stein B; Sieber P; Tutrone R; Bailen J; Goluboff E; Burzon D; Bostwick D; Steiner M
J Urol; 2006 Sep; 176(3):965-70; discussion 970-1. PubMed ID: 16890670
[TBL] [Abstract][Full Text] [Related]
4. Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.
Marshall JR; Tangen CM; Sakr WA; Wood DP; Berry DL; Klein EA; Lippman SM; Parnes HL; Alberts DS; Jarrard DF; Lee WR; Gaziano JM; Crawford ED; Ely B; Ray M; Davis W; Minasian LM; Thompson IM
Cancer Prev Res (Phila); 2011 Nov; 4(11):1761-9. PubMed ID: 21896650
[TBL] [Abstract][Full Text] [Related]
5. Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium.
Fleshner NE; Kapusta L; Donnelly B; Tanguay S; Chin J; Hersey K; Farley A; Jansz K; Siemens DR; Trpkov K; Lacombe L; Gleave M; Tu D; Parulekar WR
J Clin Oncol; 2011 Jun; 29(17):2386-90. PubMed ID: 21537051
[TBL] [Abstract][Full Text] [Related]
6. Effect of nutritional supplement challenge in patients with isolated high-grade prostatic intraepithelial neoplasia.
Joniau S; Goeman L; Roskams T; Lerut E; Oyen R; Van Poppel H
Urology; 2007 Jun; 69(6):1102-6. PubMed ID: 17572195
[TBL] [Abstract][Full Text] [Related]
7. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.
Kucuk O; Sarkar FH; Sakr W; Djuric Z; Pollak MN; Khachik F; Li YW; Banerjee M; Grignon D; Bertram JS; Crissman JD; Pontes EJ; Wood DP
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):861-8. PubMed ID: 11489752
[TBL] [Abstract][Full Text] [Related]
8. Lycopene as a chemopreventive agent in the treatment of high-grade prostate intraepithelial neoplasia.
Mohanty NK; Saxena S; Singh UP; Goyal NK; Arora RP
Urol Oncol; 2005; 23(6):383-5. PubMed ID: 16301113
[TBL] [Abstract][Full Text] [Related]
9. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia.
Clark LC; Marshall JR
Urology; 2001 Apr; 57(4 Suppl 1):185-7. PubMed ID: 11295623
[TBL] [Abstract][Full Text] [Related]
10. High-grade prostatic intraepithelial neoplasia as an exposure biomarker for prostate cancer chemoprevention research.
Marshall JR
IARC Sci Publ; 2001; 154():191-8. PubMed ID: 11220658
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of high-grade prostatic intraepithelial neoplasia in prostate gland of Korean men: comparisons between radical prostatectomy and cystoprostatectomy.
Han KS; Jeong IG; Joung JY; Yang SO; Chung J; Seo HK; Park WS; Lee KH
Urology; 2007 Dec; 70(6):1100-3. PubMed ID: 18158026
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk.
Bunker CH; McDonald AC; Evans RW; de la Rosa N; Boumosleh JM; Patrick AL
Nutr Cancer; 2007; 57(2):130-7. PubMed ID: 17571945
[TBL] [Abstract][Full Text] [Related]
13. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
[TBL] [Abstract][Full Text] [Related]
14. Larry Clark's legacy: randomized controlled, selenium-based prostate cancer chemoprevention trials.
Marshall JR
Nutr Cancer; 2001; 40(1):74-7. PubMed ID: 11799927
[TBL] [Abstract][Full Text] [Related]
15. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of prostate cancer: agents and study designs.
Thompson IM
J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117
[TBL] [Abstract][Full Text] [Related]
17. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
18. Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trial.
Capodice JL; Gorroochurn P; Cammack AS; Eric G; McKiernan JM; Benson MC; Stone BA; Katz AE
J Soc Integr Oncol; 2009; 7(2):43-51. PubMed ID: 19476738
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.
Bettuzzi S; Brausi M; Rizzi F; Castagnetti G; Peracchia G; Corti A
Cancer Res; 2006 Jan; 66(2):1234-40. PubMed ID: 16424063
[TBL] [Abstract][Full Text] [Related]
20. [Nutrition and pharmacological treatment for prevention of prostate cancer].
Segev Y; Nativ O
Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
